{"id":23374,"date":"2026-04-18T16:50:05","date_gmt":"2026-04-18T16:50:05","guid":{"rendered":"https:\/\/nationalgunowner.org\/index.php\/2026\/04\/18\/trump-cuts-wait-for-breakthrough-mental-health-treatments-for-veterans\/"},"modified":"2026-04-18T16:50:05","modified_gmt":"2026-04-18T16:50:05","slug":"trump-cuts-wait-for-breakthrough-mental-health-treatments-for-veterans","status":"publish","type":"post","link":"https:\/\/nationalgunowner.org\/index.php\/2026\/04\/18\/trump-cuts-wait-for-breakthrough-mental-health-treatments-for-veterans\/","title":{"rendered":"Trump Cuts Wait For Breakthrough Mental Health Treatments For Veterans"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div style=\"position:relative\" data-narration-container=\"true\">\n<p data-start=\"0\" data-end=\"244\">President <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Donald Trump<\/span><\/span> on Saturday signed a sweeping executive order aimed at fast-tracking access to psychedelic-based treatments for veterans suffering from PTSD, depression, and other severe mental health conditions.<\/p>\n<p data-start=\"246\" data-end=\"591\">On paper, the order directs agencies like the <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Food and Drug Administration<\/span><\/span> and the Department of Veterans Affairs to accelerate clinical trials, cut bureaucratic delays, and expand \u201cright to try\u201d access for patients who have exhausted traditional treatment options. But the real-world impact is far more immediate, and far more personal. For millions of Americans, this isn\u2019t an abstract policy debate, it\u2019s about whether treatments that show real promise are stuck in years of red tape while people continue to struggle, relapse, or fall through the cracks of a mental health system that often relies on trial-and-error prescriptions.<\/p>\n<p data-start=\"892\" data-end=\"953\">Trump framed the move as a long-overdue shift toward urgency.<\/p>\n<p data-start=\"955\" data-end=\"1170\">\u201cThese treatments are currently in the advanced stages of clinical trials to ensure that they\u2019re both safe and effective,\u201d Trump said. \u201cBut usually with things like this, nothing ever happens \u2026 we\u2019re changing that.\u201d<\/p>\n<p data-start=\"1172\" data-end=\"1519\">The executive order builds on a growing body of research suggesting psychedelic therapies, particularly compounds like ibogaine, can deliver dramatic results where conventional treatments fail. Trump pointed to a Stanford study in which special operations veterans saw an 80 to 90 percent reduction in depression and anxiety symptoms within a month.<\/p>\n<p data-start=\"1521\" data-end=\"1578\">At the signing ceremony, one veteran put it more bluntly.<\/p>\n<p data-start=\"1580\" data-end=\"1707\">\u201cThis treatment saved my life,\u201d he told the president. \u201cHelped me get off opiates \u2026 sleep for the first time in over 10 years.\u201d<\/p>\n<p data-start=\"1709\" data-end=\"1746\">\u201cAnd you have no doubt?\u201d Trump asked.<\/p>\n<p data-start=\"1748\" data-end=\"1755\">\u201cZero,\u201d he answered.<\/p>\n<p data-start=\"1757\" data-end=\"1815\">\u201cTo me, that\u2019s the best research of all,\u201d Trump said.<\/p>\n<p data-start=\"1817\" data-end=\"2304\">More than 14 million Americans suffer from serious mental illness, according to the White House <a href=\"https:\/\/www.whitehouse.gov\/fact-sheets\/2026\/04\/fact-sheet-president-donald-j-trump-is-accelerating-medical-treatments-for-serious-mental-illness\/\" target=\"_blank\" rel=\"noopener\">fact sheet<\/a> accompanying the order, and for many, existing medications and therapies simply don\u2019t work. Even when they do, they often come with significant side effects or require years of adjustments. Among veterans, the crisis is even more acute, with more than 6,000 suicides per year for over two decades, a statistic that has remained stubbornly high despite billions in federal spending.<\/p>\n<p data-start=\"2306\" data-end=\"2740\">The order attempts to break that cycle by not just funding research, but forcing the system to move faster. It directs the FDA to prioritize psychedelic drugs already designated as \u201cbreakthrough therapies,\u201d a classification reserved for treatments that show substantial improvement over existing options. It also pushes regulators to shorten review timelines that can typically stretch close to a year, and in some cases, much longer.<\/p>\n<p data-start=\"2742\" data-end=\"3049\">At the same time, the administration is expanding access before full approval. By opening a clearer pathway under federal right-to-try laws, patients with treatment-resistant conditions may be able to access these therapies under medical supervision rather than waiting years for final regulatory clearance.<\/p>\n<p data-start=\"3051\" data-end=\"3273\">That shift could prove significant not just for veterans, but for civilians facing similar conditions; first responders, trauma survivors, and millions of Americans dealing with depression, addiction, and anxiety disorders.<\/p>\n<p data-start=\"3275\" data-end=\"3673\">Health agencies are also being pushed to coordinate more aggressively. The order mandates increased data sharing between federal departments, expanded clinical trial participation, and at least $50 million in federal support for state-level research efforts. States like Texas have already invested heavily in ibogaine research, and the federal government is now stepping in to match those efforts.<\/p>\n<p data-start=\"3675\" data-end=\"3756\">Even skeptics in the medical field say the evidence is becoming harder to ignore.<\/p>\n<p data-start=\"3758\" data-end=\"3962\">\u201cOne single administration can change behavior toward a therapeutic effect,\u201d a researcher at the signing said. \u201cWe have a tool that could allow the body to heal itself, if we know how to properly use it.\u201d<\/p>\n<p data-start=\"3758\" data-end=\"3962\">That\u2019s the gamble behind the order: that accelerating access doesn\u2019t just help veterans, but could reshape how the country approaches mental health treatment altogether, moving away from long-term symptom management and toward therapies that may offer more lasting change.<\/p>\n<p data-start=\"4237\" data-end=\"4548\">For everyday Americans, the implications are straightforward. If these treatments continue to show results, they won\u2019t remain confined to niche trials; they could become part of mainstream medicine, available through doctors rather than years-long waitlists or costly alternatives abroad.<\/p>\n<p data-start=\"4550\" data-end=\"4701\">If these therapies work \u2014 and early data suggest they might \u2014 the question is no longer whether they should exist, but how quickly people can access them.<\/p>\n<p data-start=\"4703\" data-end=\"4755\" data-is-last-node=\"\" data-is-only-node=\"\">Trump\u2019s answer, at least for now, is simple: faster.<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.dailywire.com\/news\/trump-cuts-wait-for-breakthrough-mental-health-treatments-for-veterans\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>President Donald Trump on Saturday signed a sweeping executive order aimed at fast-tracking access to psychedelic-based treatments for veterans suffering from PTSD, depression, and other severe mental health conditions. On paper, the order directs agencies like the Food and Drug Administration and the Department of Veterans Affairs to accelerate clinical trials, cut bureaucratic delays, and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":23375,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","footnotes":""},"categories":[14],"tags":[],"class_list":{"0":"post-23374","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-current-news"},"_links":{"self":[{"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/posts\/23374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/comments?post=23374"}],"version-history":[{"count":0,"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/posts\/23374\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/media\/23375"}],"wp:attachment":[{"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/media?parent=23374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/categories?post=23374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nationalgunowner.org\/index.php\/wp-json\/wp\/v2\/tags?post=23374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}